The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
DE VRIES, T. A. C., PECEN, Ladislav, KOMEN, J. J., DE GROOT, J. R., KIRCHHOF, P., DE CATERINA, R. The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe. European Heart Journal. 2022, 43(Suppl. 2), 618-618. ISSN 0195-668X. E-ISSN 1522-9645 Dostupné z: doi:10.1093/eurheartj/ehac544.618
